[{"id":"7e54d1c6-d408-4982-8507-ad0564767413","acronym":"","url":"https://clinicaltrials.gov/study/NCT00988715","created_at":"2021-01-18T03:51:45.484Z","updated_at":"2024-07-02T16:37:18.320Z","phase":"Phase 1","brief_title":"Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome","source_id_and_acronym":"NCT00988715","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e fludarabine IV • cyclosporin A microemulsion • BC8-SA"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 04/21/2010","start_date":" 04/21/2010","primary_txt":" Primary completion: 01/01/2015","primary_completion_date":" 01/01/2015","study_txt":"","study_completion_date":"","last_update_posted":"2017-08-30"}]